Ox-LDL Particles: Modified Components, Cellular Uptake, Biological Roles and Clinical Assessments

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 11, Iss. 2, 2011-01 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Modified LDL Antibodies and LDL-Containing Immune Complexes in IDDM Patients and Healthy Controls

By Mironova M.   Virella G.   Virella-Lowell I.   Lopes-Virella M.F.  

Clinical Immunology, Vol. 85, Iss. 1, 1997-10 ,pp. : 73-82

Academic Press

Access to resources Recommend Favorite

Antibodies to Oxidized LDL and LDL-Containing Immune Complexes as Risk Factors for Coronary Artery Disease in Diabetes Mellitus

By Lopes-Virella M.F.   Virella G.   Orchard T.J.   Koskinen S.   Evans R.W.   Becker D.J.   Forrest K.Y.Z.  

Clinical Immunology, Vol. 90, Iss. 2, 1999-02 ,pp. : 165-172

Academic Press

Access to resources Recommend Favorite

Human Monoclonal Antibodies: Immune Complexes and Cryoglobulins

By Bernier George M.  

Allergy and Asthma Proceedings, Vol. 3, Iss. 2, 1982-0 ,pp. : 304-307

OceanSide Publications, Inc

Access to resources Recommend Favorite

Hypochlorite-Modified LDL: Chemotactic Potential and Chemokine Induction in Human Monocytes

By Woenckhaus C.   Kaufmann A.   Busfeld D.   Gemsa D.   Sprenger H.   Grone H.J.  

Clinical Immunology, Vol. 86, Iss. 1, 1998-01 ,pp. : 27-33

Academic Press

Access to resources Recommend Favorite